Widely regarded as arguably the best OTC fat burner and appetite suppressant pill, PhenQ helps users tackle fat loss from ...

REDMOND, Wash., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Emerald Communities is proud to announce the appointment of Ron Schaefer as the new President and Chief Executive Officer of Emerald Communities, ...

Privia Health will pay $100 million in cash at closing and up to an additional $13 million subject to final MSSP performance for 2025. The transaction is expected to close in the fourth quarter of ...

Based on the proxies received and the vote conducted at the Meeting, all tabled resolutions were approved by the shareholders of the Company (the “Shareholders ”), including the election of the ...

SOUTH SAN FRANCISCO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to present a ...

The RSU award and stock options were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635 (c) (4) under the Inducement ...

A live webcast presentation will be accessible on the company’s website, www.aardvarktherapeutics.com, under the investors section, and an archived recording will be available on the website for ...

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today highlights emerging scientific evidence linking ...

Cyclerion Therapeutics, Inc. today announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology (“MIT”), securing the intellectual property that will serve ...

NANTES, France – September 23, 2025, 10:30 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) acknowledges the decision rendered on September 23, 2025, by the Nantes Commercial ...

With its growing network of centers across the Middle East, Nyxoah continues to deliver on its commitment to expand patient access to Genio, the only leadless, externally powered bilateral hypoglossal ...

Biogen is working with regulatory authorities around the world to advance the high dose regimen as an additional dosing option for people living with SMA. The high dose regimen of SPINRAZA (nusinersen ...